Is this your Brand? Log in to Hoodie!
Log in to HoodieNira+
Data Snapshot for Mar 20, 2026
Overview
We develop high-quality, THC and CBD-rich products aimed at improving the quality of life for cannabis patients. With deep roots in science and medicine, we are focused on purity and consistency. Our products offer patients new options for improved wellness.
NIRA+ achieved a staggering 115.5% YoY growth, propelling its rank from #6 to #2 in Virginia. Recent trends show a 23.5% increase over the last three months, despite a slight dip of 7.9% in sales. Positioned in the premium tier, this brand exemplifies strength in a competitive landscape.
Categories
- Top Category: Concentrates
- Price Tier: Premium
- States Active: 2
Top States
Nira+ Top StatesFeb 2026
Top states where Nira+ is active based on indexed sales coverage.
Trend View
Market Insights SnapshotFeb 2026
Trend narrative unavailable.
24-Month Trend
Average Price
$40.13
YoY Sales Trend
115.5%
2Y Sales Trend
204.5%
Concentrates dominate at 67.1%, boasting an impressive 363.4% YoY growth, while Oral products account for 31.3% with a slight decline of 2.1% YoY. Topicals make up just 1.6%, illustrating the overwhelming preference for Concentrates in the market.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Concentrates | 67.1% | $39.44 | 363.4% |
| Oral | 31.3% | $43.36 | 2.1% |
| Topicals | 1.6% | $23.54 | N/A |
NIRA+ leads in Virginia with 68.9% of sales, followed by Pennsylvania at 30.0%, and a minimal presence in Massachusetts at 1.1%. This geographic concentration underscores its strong foothold in key cannabis markets.
| State | Concentrates | Oral | Topicals |
|---|---|---|---|
| 2 | 1 | 4 | |
| 19 | 10 | ⊖ |
Want SKU-Level Buyer Signals?
Unlock purchaser contacts, SKU-level velocity, and whitespace opportunities for this brand.
Market Position
Competitive LandscapeFeb 2026
NIRA+ ranks #2 in the lucrative Concentrates category, gaining ground on competitors like THE LAB, AMBER, and RYTHM. This impressive leap from #6 to #2 over the past year highlights its competitive edge in a rapidly evolving market.
SKU View
Notable ProductsFeb 2026
Top products for Feb 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1 ![Thc [30ml]](/_next/image?url=https%3A%2F%2Fdata-item-images.s3.us-east-2.amazonaws.com%2Fsuccess%2Fdf7ed7088165bb3b7ae8ab68ea88c241&w=64&q=75){kind=small} | Oral | 13.1% |
#2  | Concentrates | 108.1% |
#3 | Concentrates | N/A |
#4 | Concentrates | 21.9% |
#5  | Oral | 2.4% |
#6  | Concentrates | 9.1% |
#7 | Concentrates | 46.9% |
#8 | Concentrates | 11.1% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Nira+ using competitive landscape rank coverage, proximity, and momentum.
